Ubrelvy™ (ubrogepant) Approved by FDA for Acute Migraine Treatment
This article represents the opinions, thoughts, and experiences of the author; none of this content has been paid for by any advertiser. The Migraine.com team does not recommend or endorse any products or treatments discussed herein. Learn more about how we maintain editorial integrity here.
- Dodick DW, Lipton RB, et al. Ubrogepant for the treatment of migraine. The New England Journal of Medicine. 5 Dec 2019; 381, 2230-41.
- Lipton RB, Dodick DW, et al. Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: The ACHIEVE II randomized clinical trial. JAMA. 19 Nov 2019; 322(19), 1887-98.